Home Patent Forecast® Sectors Log In   Sign Up   Support   Contact  
Why Patent Forecast® What's Included Patent Forecast® Sectors Free Trial Pricing News Feed Subscribe Menu

Patent 10378020
Trait Biosciences, Inc.

High Level In Vivo Biosynthesis And Isolation Of Water-soluble Cannabinoids In Plant Systems

The inventive technology relates to systems and methods for enhanced in vivo production, accumulation and modification of cannabinoids. In one embodiment, the invention may include systems and methods for enhanced in vivo biosynthesis of chemically-modified water-soluble cannabinoids in a whole plant, or a cell suspension culture system.

Much More than Average Length Specification


1 Independent Claims

  • Claim 1. A method for the production of water-soluble cannabinoids in a Cannabis cell cytosol: genetically modifying a cultured Cannabis cell to transiently express: i. anucleotide sequence encoding at least one cannabinoid synthase having its trichome targeting signal disrupted or removedii. a nucleotide sequence encoding a heterologous cytochrome P450 having hydroxylation or oxidation activity toward a cannabinoidto generate a hydroxylated cannabinoid or a cannabinoid carboxylic acidiii. a nucleotide sequence encoding a heterologous P450 oxidoreductase that facilitates electron transfer from nicotinamide adenine dinucleotide phosphate (NADPH) to thecytochrome P450and iv. a nucleotide sequence encoding a heterologous glycosyltransferase having glycosylation activity towards said cannabinoids, said hydroxylated cannabinoids, and said cannabinoid carboxylic acids.
  • Claim 13. A method for producing water-soluble cannabinoids in the cytosol of a plant comprising the steps: genetically modifying at least one Cannabis plant through Agrobacterium-mediated transformation to transiently express: i. a nucleotidesequence encoding at least one cannabinoid synthase having its trichome targeting signal disrupted or removedii. a nucleotide sequence encoding a heterologous cytochrome P450 having hydroxylation or oxidation activity towards a cannabinoid togenerate a hydroxylated cannabinoid, or a cannabinoid carboxylic acidiii. a nucleotide sequence encoding a heterologous P450 oxidoreductase that facilitates electron transfer from NADPH to the cytochrome P450and iv. a nucleotide sequence encodinga heterologous glycosyltransferase having glycosylation activity towards said cannabinoids, said hydroxylated cannabinoids, and said cannabinoid carboxylic acids.
  • Claim 16. A method for producing water-soluble cannabinoids in a Cannabis plant cell comprising the steps: genetically modifying at least one Cannabis plant cell through Agrobacterium-mediated transformation to transiently express: i. a nucleotidesequence encoding at least one cannabinoid synthase having its trichome targeting signal disrupted or removedii. a nucleotide sequence encoding a heterologous cytochrome P450 having hydroxylation or oxidation activity towards a cannabinoid togenerate a hydroxylated cannabinoid, or a cannabinoid carboxylic acidiii. a nucleotide sequence encoding a heterologous P450 oxidoreductase that facilitates electron transfer from NADPH to the cytochrome P450and iv. a nucleotide sequence encodinga heterologous glycosyltransferase having glycosylation activity towards said cannabinoids, said hydroxylated cannabinoids, and said cannabinoid carboxylic acidsv. a nucleotide sequence encoding an endogenous or heterologous myb transcription factorwherein said heterologous or heterologous myb transcription factor increases cannabinoid production by enhancing metabolite flux through the cannabinoid biosynthetic pathwayand vi. a nucleotide sequence encoding a heterologous catalase havingreduction activity towards hydrogen peroxide generated by cannabinoid biosynthesis.
  • Claim 17. A method for producing water-soluble cannabinoids in a Cannabis cell comprising the steps: genetically modifying at least one Cannabis cell to transiently express: i. a nucleotide sequence encoding at least one cannabinoid synthase havingits trichome targeting signal disrupted or removedii. a nucleotide sequence encoding a heterologous cytochrome P450 having hydroxylation or oxidation activity towards a cannabinoid to generate a hydroxylated cannabinoid, or a cannabinoid carboxylicacidiii. a nucleotide sequence encoding a heterologous P450 oxidoreductase that facilitates electron transfer from NADPH to the cytochrome P450and iv. a nucleotide sequence encoding a heterologous glycosyltransferase having glycosylation activitytowards said cannabinoids, said hydroxylated cannabinoids, and said cannabinoid carboxylic acidsv. a nucleotide sequence encoding an endogenous or heterologous myb transcription factor wherein said heterologous or heterologous myb transcription factorincreases cannabinoid production by enhancing metabolite flux through the cannabinoid biosynthetic pathwayand vi. a nucleotide sequence encoding a heterologous catalase having reduction activity towards hydrogen peroxide generated by cannabinoidbiosynthesis.